How HERV-W activation could influence the dual role played by NK cells in MS, as inflammatory mediators of damage and as immune regulatory cells suppressing harmful inflammatory activity [73], remains to be elucidated. This evidence concerns the gene ERVW-1 and myeloid sarcoma.